Toward Platelet Transcriptomics in Cancer Diagnosis, Prognosis and Therapy

The authors present a few actionable steps for basic, translational and clinical research communities in advancing the utility of the platelet transcriptome as a highly sensitive biomarker in cancer and collectively enable efforts toward clinical translation and patient benefit.